ClinicalTrials.gg
CompletedNCT04102358Updated Feb 20, 2024

The Need for Supplemental Blocks in Infraclavicular Brachial Plexus Blocks

An observational study in Anesthesia, Regional, sponsored by Derince Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 14 Years and older. Per ClinicalTrials.gov, last updated 2024-02-20.

Sponsored by Derince Training and Research Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
139
Ages
14 Years and older
Sex
All
01

Study summary

Theoretically, all surgeries below mid-humerus can be done under infraclavicular (IC) blocks. Following the introduction of ultrasonography (USG) to clinical anesthesia, plexus, and nerve blocks under the guidance of USG have gained wide acceptance for the high rates of block success and low risk of complications (1). In this study, the main aim is to evaluate the single injection and triple injection techniques in IC blocks with a USG-guided medial approach in terms of block success and the need for supplementary blocks. The secondary goals are to compare the complication rates and sensory block durations and to discuss the possible reasons for the failure of the blocks.

Read the detailed description

Theoretically all surgeries below mid-humerus can be done under infraclavicular (IC) blocks. Following the introduction of ultrasonography (USG) to the clinical anesthesia, plexus and nerve blocks under the guidance of USG have gained wide acceptance for the high rates of block success, and low risk of complications. At the same time, it was also shown that USG-guided IC blocks can shorten procedural times and accelerate the onset of the blocks.

Several methods for IC blocks have been described. Based on the anatomical knowledge, we hypothesized that in medial approaches the need for supplementary blocks would be low with single injections as well as triple injections. In this study, the main aim is to evaluate the single injection and triple injection techniques in IC blocks with a USG-guided medial approach in terms of block success and the need for supplementary blocks. The secondary goals are to compare the complication rates and sensory block durations and to discuss the possible reasons for the failure of the blocks.

Medical records of 139 patients scheduled for elective or emergent hand, wrist, forearm, elbow, and distal arm surgery were analyzed. Patients older than 14 years with ASA physical status I-III who underwent surgery between October 2017 and March 2019 were retrospectively evaluated. Exclusion criteria included non-cooperative patients, refusal of the regional anesthesia, known neuropathy that could prevent the evaluation of the efficacy of the block, different techniques used for infraclavicular brachial plexus blocks (lateral sagittal, coracoid, ...etc.), and known allergy to local anesthetic drugs.

02

Conditions studied

  • Anesthesia, Regional

Keywords

  • Vertical infraclavicular block
  • brachial plexus anatomy
03

In context

Lead sponsor

Derince Training and Research Hospital is the lead sponsor of 39 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
14 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patients underwent surgery for upper extremity under medial approach infraclavicular block between October 2017 and March 2019

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • I-III
  • upper extremity surgery
  • blocks were performed by the same anesthesiologist

Exclusion criteria

Exclusion Criteria:

  • non-cooperative patients
  • refusal of the regional anesthesia
  • known neuropathy
  • different technique used for infraclavicular brachial plexus blocks (lateral sagittal, coracoid, ...etc.)
  • known allergy to local anesthetic drugs.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
139 participants (actual)
Patient registry
No

Groups and cohorts

  • Single injection

    Patients who received an infraclavicular block with a single injection technique were included in Group-S.

    Procedure: Medial approach infraclavicular block with single injection

  • Triple injection

    Patients who received an infraclavicular block with a triple injection technique were included in Group-T.

    Procedure: Medial approach infraclavicular block with triple injection

Interventions

  • ProcedureMedial approach infraclavicular block with single injection

    infraclavicular blocks performed with single injection

  • ProcedureMedial approach infraclavicular block with triple injection

    infraclavicular blocks performed with triple injection

06

What researchers measure

Primary outcomes

  1. Supplemented blocks

    30 minutes after the block, if one or two of the median, radial, ulnar or musculocutaneous nerves were still unblocked, these nerves were located either with a peripheric nerve stimulator or an ultrasound, in the axilla or on the more distal parts of their traces on arm and forearm and then supplemented.

    Time frame: 1 hour

Secondary outcomes

  1. Complete Failure

    If more than two of these nerves (median, radial, ulnar or musculocutaneous) were remained unblocked, no supplementary blocks were applied, then it was considered as having a failed block and general anesthesia was administered.

    Time frame: 30 minutes

  2. Recovery of sensory block

    the first time of the need for analgesics

    Time frame: 24 hours

  3. Discomfort during IC block

    paresthesia during the infraclavicular block

    Time frame: 1 hour

  4. Inadvertent vascular puncture

    inadvertent vascular puncture during the infraclavicular block

    Time frame: 1 hour

07

Study locations

1 site
  • Derince Training and Research Hospital
    Kocaeli, Derince 41900, Turkey
08

References and documents

Publications

  • Abrahams MS, Aziz MF, Fu RF, Horn JL. Ultrasound guidance compared with electrical neurostimulation for peripheral nerve block: a systematic review and meta-analysis of randomized controlled trials. Br J Anaesth. 2009 Mar;102(3):408-17. doi: 10.1093/bja/aen384. Epub 2009 Jan 26. PubMed 19174373 ↗
  • Li JW, Songthamwat B, Samy W, Sala-Blanch X, Karmakar MK. Ultrasound-Guided Costoclavicular Brachial Plexus Block: Sonoanatomy, Technique, and Block Dynamics. Reg Anesth Pain Med. 2017 Mar/Apr;42(2):233-240. doi: 10.1097/AAP.0000000000000566. PubMed 28157792 ↗
  • Kilka HG, Geiger P, Mehrkens HH. [Infraclavicular vertical brachial plexus blockade. A new method for anesthesia of the upper extremity. An anatomical and clinical study]. Anaesthesist. 1995 May;44(5):339-44. doi: 10.1007/s001010050162. German. PubMed 7611581 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data for all primary and secondary outcome measures will be made available.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Data will be available within 6 months of study completion.

Access criteria: Data access requests will be reviewed by the researchers. Requestors will be required to sign a Data Access Agreement.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2017 to primary completion in Mar 2019, 17 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 23, 2019
First posted
Sep 25, 2019
StartActual
Oct 1, 2017
Primary completionActual
Mar 31, 2019
CompletionActual
May 30, 2019
Last update
Feb 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04102358
Lead sponsor
Derince Training and Research Hospital
Responsible party
Hande Gurbuz (Principal Investigator, Derince Training and Research Hospital) — Principal investigator
First posted
Sep 25, 2019
Start date
Oct 1, 2017
Primary completion
Mar 31, 2019
Completion
May 30, 2019
Last update
Feb 20, 2024

Study contacts

Tuncay Colak, Prof
study chair · Kocaeli University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion